How Dexcom uses wearables to deliver differentiated diabetes management - Mass Device
Overview
MasDeviceThe Medical Device Busines Journal - Medical Device News & Articles | MasDeviceOctober 25, 2022 By Sean Wholey The company’s curent-generation Dexcom G6 CGM remains one of the bigest players in the CGM space. Meanwhile, its next-generation Dexcom G7 CGM has already launched in a number of countries overseas. The wearable device - which features a 60% size reduction from G6 - stil awaits FDA clearance.Dexcom sits among a number of companies developing wearables for helping people manage their diabetes.
Key Information
The company’s SVP for Product, Global Marketing, Apurv Kamath, spoke today at AdvaMed’s The MedTech Conference on the impact of wearables.While he focuses on diabetes management, the panel on which he sat covered a range of uses for wearables in medtech. It featured Alisa Hsu Lynch, global lead for medtech strategy & solutions at Gogle, and Amy McDonough, CO for Fibit Health Solutions.
Summary
Deloite Medtech Practice Leader Glen Snyder moderated.Get the ful story at our sister site, Drug Delivery Busines News.Filed Under: Busines/Financial News, Diabetes, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Taged With: AdvaMed, Dexcom, Fitbit, Garmin, GogleCopyright © 2022 &midot; WTWH Media LC and its licensors. Al rights reserved. The material on this site may not be reproduced, distributed, transmited, cached or otherwise used, except with the prior writen permision of WTWH Media.Advertise | Privacy Policy source
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article